Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Treatment

UK Patients To Benefit From Access To Innovative Lung Cancer Treatment
The National Institute for Health and Clinical Excellence (NICE) have today published their
generic viagra online
Senate Minority Leader McConnell Says He Will Oppose Sotomayor As Other Republicans Back Nominee
Senate Minority Leader Mitch McConnell (R-Ky.) on Friday announced that he will oppose Supreme Court nominee Sonia Sotomayor, even as increased Republican support seemed to ensure that she would be confirmed, the New York Times reports. McConnell said that he would not support Sotomayor"s nomination because her "record of written statements suggests an alarming lack of respect for the notion of equal justice, and, therefore, in my view, an insufficient willingness to abide by the judicial oath." McConnell intends to deliver the remarks to the Senate on Monday. Meanwhile, Republican Sens. Richard Lugar (Ind.), Mel Martinez (Fla.) and Olympia Snowe (Maine) said that they would support Sotomayor. The Times reports that the senators" backing of Sotomayor -- combined with her "solid Democratic support" -- shows that she should receive "strong confirmation approval" (Hulse, New York Times, 7/18). Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) and ranking member Jeff Sessions (R-Ala.) would not predict how many Republicans could vote for her confirmation. Sessions said that Republicans are seeking a committee vote on Sotomayor on July 28, one week later than the date sought by committee Democrats. During that week, Republicans hope to review her record, her answers from her confirmation hearings and other responses to questions (AP/Boston Globe, 7/20).
News of the day
Stem Cell Industry Expert Praises, Encourages Continued Progress On Legislation To Promote Benefits Of Cord Blood
Mercedes Walton, CEO of Cryo-Cell International, one of the largest and most established family cord blood banks, is praising legislative progress to date and encouraging continued momentum for existing bills through the second half of the year. H.R. 1718, the "Family Cord Blood Banking Act," and H.R. 2107, the "Cord Blood Education and Awareness Act of 2009" would continue to build on the progress from the first half of the year to enable and promote the continued research, public awareness and tax benefits related to storing and using cord blood, all of which provide great benefit to families across America.
Mental Health

New Supplement May Help Slow Sight Loss In Elderly

Queen"s University Belfast academics have helped develop an antioxidant supplement which may slow down sight loss in elderly people. The supplement may help those affected by the leading cause of blindness in the Western World, a five-year research programme has found. Professor Usha Chakravarthy, from Queen"s Centre of Vision and Vascular Science (CVVS), co-ordinated the study, which looked at nutritional supplements for patients with early age-related macular (AMD) degeneration and found they helped sharpen vision. Details of the findings are being presented in Belfast today (Friday) by Professor Chakravarthy and Dr Stephen Beatty, Head of Vision Research at the Waterford Institute of Technology. They co-designed the study and the antioxidant supplement was developed with the advice of Professor Ian Young from the School of Medicine, Dentistry and Biomedical Sciences at Queen"s and scientists in eyecare companies Dr Mann Pharma and Bausch and Lomb. AMD is an incurable eye disease which causes blurring of central vision because of its effects on the macula, the central part of the retina. Over 400 people across Ireland took part in clinical trials investigating whether carotenoids, rich antioxidants which are found in fruit and vegetables, could prevent progression to the more serious late AMD. When the eye disease progresses to late AMD patients are unable to read, watch television or recognise people"s faces as they only have peripheral vision, not central vision. Professor Chakravarthy, who is also a Consultant Ophthalmic Surgeon at the Royal Hospital in Belfast, said: "Late AMD causes severe sight loss and has a huge economic impact both in terms of the effects of sight loss itself and in terms of the expensive treatments that are needed to deal with the condition. "Up to 500 people a year in Northern Ireland will lose sight in one or both eyes as a result of late AMD. "We wanted to carry out the study as prevention of progression to late AMD can result in a reduced financial and societal burden." As the macula of the eye is very rich in antioxidants the researchers wanted to see if a supplement called CARMA (Caroteneoids and Co-antioxidants in Age-related Maculopathy) containing the carotenoids lutein and zeaxanthin could help slow down AMD. The supplement also contained vitamins C,E and Zinc, which had been used in a previous study. The latest study showed that intake of high levels of both carotenoids preserved the macular pigments, slowing down the progression from early AMD to late AMD. In contrast, the macular pigments of participants in a placebo group declined steadily. Dr Chakravarthy added: "These findings are important because this is the first randomised controlled clinical trial to document a beneficial effect through improved function and maintained macular pigments. "Further research is needed to confirm these findings and to identify the numbers needed to treat to prevent 1 case from progressing from early to late AMD." The study was funded by Dr Mann Pharma and Bausch and Lomb and sponsored by the Belfast Health and Social Care Trust. Queen"s University Belfast


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009